Kiniksa Pharmaceuticals to Report First Quarter 2026 Financial Results on AprilĀ 28, 2026

Go back to Kiniksa Pharmaceuticals to Report First Quarter 2026 Financial Results on AprilĀ 28, 2026
(NASDAQ: KNSA) Delayed: 57.13 --0 (-0%)
Previous Close $57.13    52 Week High
Open $57.13    52 Week Low
Day High $57.13    P/E N/A 
Day Low $57.13    EPS
Volume